Moody’s affirms ‘Baa2’ rating on Holy Name Medical Center’s bonds

Moody’s Investors Service affirmed the “Baa2” rating on Teaneck, N.J.-based Holy Name Medical Center’s approximately $40 million of revenue bonds.

Advertisement

The ratings affirmation reflects the medical center’s stable market position, conservative debt structure and defined contribution pension plan limiting unanticipated calls on liquidity.

The ratings agency revised the medical center’s outlook to negative from stable. The revision is a result of the medical center’s weaker-than-budgeted operating performance in fiscal year 2016 with similarly weak performance expected for FY 2017 as the hospital continues to absorb increased expenses related to its physician employment strategy.

More articles on healthcare finance:
Moody’s affirms ‘A1’ rating on Jackson-Madison County General Hospital’s outstanding debt
Moody’s assigns ‘Caa1’ rating to Good Shepherd Health System’s bonds
Moody’s assigns ‘A1’ rating to Children’s Hospital & Medical Center’s bonds

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.